Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381.
Pharmacol Rev. 2022.
PMID: 34987087
Free PMC article.
Review.
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
Penington DJ, Bryant I, Riese DJ 2nd.
Penington DJ, et al.
Cell Growth Differ. 2002 Jun;13(6):247-56.
Cell Growth Differ. 2002.
PMID: 12114214
Item in Clipboard
Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.
Gallo RM, Bryant I, Fry R, Williams EE, Riese DJ 2nd.
Gallo RM, et al.
Biochem Biophys Res Commun. 2006 Oct 13;349(1):372-82. doi: 10.1016/j.bbrc.2006.08.055. Epub 2006 Aug 18.
Biochem Biophys Res Commun. 2006.
PMID: 16934755
Free PMC article.
Item in Clipboard
Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.
Gallo RM, Bryant IN, Mill CP, Kaverman S, Riese DJ 2nd.
Gallo RM, et al. Among authors: bryant in.
J Cancer Res Ther Oncol. 2013 Aug 22;1(1):10.
J Cancer Res Ther Oncol. 2013.
PMID: 24791013
Free PMC article.
Item in Clipboard
A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines.
Williams EE, Trout LJ, Gallo RM, Pitfield SE, Bryant I, Penington DJ, Riese DJ 2nd.
Williams EE, et al.
Cancer Lett. 2003 Mar 20;192(1):67-74. doi: 10.1016/s0304-3835(02)00690-0.
Cancer Lett. 2003.
PMID: 12637154
Item in Clipboard
Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
Pitfield SE, Bryant I, Penington DJ, Park G, Riese DJ 2nd.
Pitfield SE, et al.
Oncol Res. 2006;16(4):179-93. doi: 10.3727/000000006783981134.
Oncol Res. 2006.
PMID: 17120616
Free PMC article.
Item in Clipboard
Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation.
Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese DJ 2nd, Settleman J, Haber DA.
Godin-Heymann N, et al.
Cancer Res. 2007 Aug 1;67(15):7319-26. doi: 10.1158/0008-5472.CAN-06-4625.
Cancer Res. 2007.
PMID: 17671201
Free PMC article.
Item in Clipboard
Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.
VanBrocklin HF, Lim JK, Coffing SL, Hom DL, Negash K, Ono MY, Gilmore JL, Bryant I, Riese DJ 2nd.
VanBrocklin HF, et al.
J Med Chem. 2005 Nov 17;48(23):7445-56. doi: 10.1021/jm050607w.
J Med Chem. 2005.
PMID: 16279804
Item in Clipboard
Cite
Cite